Shimoda, Hiroo
Taniguchi, Masatomo
Yamamoto, Suguru
Igarashi, Ataru
Tokunaga, Shin
Hanada, Keigo
Tashiro, Naoki
Murata, Tatsunori
Asada, Shinji
Funding for this research was provided by:
Kyowa Kirin Co., ltd.
Article History
Received: 12 June 2025
Accepted: 8 September 2025
First Online: 9 October 2025
Declarations
:
: This research was entirely funded by Kyowa Kirin Co., Ltd.Masatomo Taniguchi received honoraria from Kyowa Kirin Co., Ltd., Bayer Yakuhin Ltd., Mitsubishi Tanabe Pharma Corporation, Kissey Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Torii Pharmaceutical Co., Ltd., and Daiichi Sankyo Company Ltd. Suguru Yamamoto received honoraria and consulting fees from Sanwa Kagaku Kenkyusho Co., Ltd.; honoraria from Kyowa Kirin Co., Ltd., Kissei Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., and Torii Pharmaceutical Co., Ltd.; and research funding from Toray Medical Co., Ltd. and Kaneka Medix Co., Ltd. Ataru Igarashi received honoraria from Kyowa Kirin Co., Ltd., Bayer Yakuhin Ltd., Mitsubishi Tanabe Pharma Corporation, Ono Pharmaceutical Co., Ltd., Astra Zeneca K.K., Toray Medical Co., Ltd., Novo Nordisk Pharma Ltd. and Eli Lilly Japan K.K. Hiroo Shimoda, Shin Tokunaga, and Shinji Asada are employees of Kyowa Kirin Co., Ltd.Keigo Hanada, Naoki Tashiro, and Tatsunori Murata are employees of CRECON Medical Assessment Inc.